ClinicalTrials.gg
Sign In
CompletedNCT03497078LEHRSUpdated May 6, 2019

Comparison of Image Quality Between New Collimator LEHRS vs Siemens LEHR on Bone Scintigraphy

An interventional study of Bone scintigraphy in Comparison of Two Collimators During Bone Scintigraphy, sponsored by Centre Hospitalier Régional d'Orléans. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-05-06.

Sponsored by Centre Hospitalier Régional d'Orléans · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Comparison of quality image with a new LEHRS GE collimator vs standard LEHR Siemens collimator on bone scintigraphy.

02

Conditions studied

  • Comparison of Two Collimators During Bone Scintigraphy

Keywords

  • collimator
  • bone scintigraphy
  • image quality
  • scintigraphy
03

In context

Lead sponsor

Centre Hospitalier Régional d'Orléans is the lead sponsor of 132 studies on the registry; 32 are open to participants now.

Browse Centre Hospitalier Régional d'Orléans studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Refered patients for scintigraphy

Exclusion criteria

Exclusion Criteria:

  • Under 18 y. old patients
  • Pregnancy or supposed to be pregnant patients
  • Kidney failure
  • Painful patients
  • Patients under guardianship
  • Patients in whom a standard exam is not feasible
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
82 participants (actual)

Study arms

  • Other
    Refered patients for scintigraphy

    Other: Bone scintigraphy

Interventions

  • OtherBone scintigraphy

    Comparison of image quality between new collimator LEHRS (General Electric - GE Healthcare) vs Siemens LEHR on bone scintigraphy.

06

What researchers measure

Primary outcomes

  1. visual quality of bone exams

    Time frame: Day 0

Secondary outcomes

  1. Quantitative signal-noise-ratios

    Time frame: Day 0

  2. quantitative datas on phantom

    Time frame: Day 0

07

Study locations

1 site
  • CHR d'Orléans
    Orléans, 45067, France
08

References and documents

Publications

  • Gilland DR, Welch BL, Lee S, Kross B, Weisenberger AG. Evaluation of a novel collimator for molecular breast tomosynthesis. Med Phys. 2017 Nov;44(11):5740-5748. doi: 10.1002/mp.12564. Epub 2017 Oct 13. PubMed 28877351 ↗
  • Songy B, Lussato D, Guernou M, Queneau M, Geronazzo R. Comparison of myocardial perfusion imaging using thallium-201 between a new cadmium-zinc-telluride cardiac camera and a conventional SPECT camera. Clin Nucl Med. 2011 Sep;36(9):776-80. doi: 10.1097/RLU.0b013e31821a294e. PubMed 21825848 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2018 to primary completion in Mar 2019, 11 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 6, 2018
First posted
Apr 13, 2018
StartActual
Apr 3, 2018
Primary completionActual
Mar 18, 2019
CompletionActual
Mar 18, 2019
Last update
May 6, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 6, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03497078
Lead sponsor
Centre Hospitalier Régional d'Orléans
Responsible party
Sponsor
First posted
Apr 13, 2018
Start date
Apr 3, 2018
Primary completion
Mar 18, 2019
Completion
Mar 18, 2019
Last update
May 6, 2019

Study contacts

Gilles METRARD, Dr
principal investigator · CHR d'Orléans

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Centre Hospitalier Régional d'Orléans →

Start the discussion